Trial Profile
A Phase I Clinical Trial Assessing the Safety, Pharmacokinetics, Pharmacodynamics, and Disintegration Time of Vaginal Tablets Containing Tenofovir and/or Emtricitabine
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Emtricitabine; Tenofovir disoproxil fumarate
- Indications Hepatitis B; HIV infections
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 31 Mar 2015 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 11 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Feb 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.